ECHINOCOCCOSIS OF LUNGS COMPLICATED BY PECILOMYCOSIS
To date, large-scale targeted measures have been taken in the domestic healthcare sector to radically improve the quality and significantly expand the range of medical care provided to the population. In this direction, especially in improving the quality of treatment of echinococcosis, positive results have been achieved. Along with this, to improve the system of medical care, scientific-based results are required to assess the effectiveness of new methods of prevention and treatment of hydatids liver diseases. Among the most relevant aspects of the problem of echinococcosis are the identification of factors that affect the development of the disease, the causes of complications and relapses. It, along with numerous States, is also quite often found on the territory of Central Asian countries, which includes Uzbekistan. It is safe to say that echinococcosis today is one of the most important world problems of medical, veterinary and biological significance. Echinococcosis is a serious human disease that affects various organs, especially the liver and lungs, and more than 1.5 thousand operations are performed for it per year; only in terms of referrals to surgical clinics, the incidence rate ranges from 4 to 9 per 100 thousand people; the number of patients with complicated forms reaches 25-45% the number of postoperative complications – 20-30 %; lethality – 2-5 %. In some regions of the Republic, the incidence of echinococcosis in people as a result of indirect hemagglutination is 8-9%, according to autopsy data-2-3 %. The main role in the complex of anti-helminth measures continues to play a specific deworming of animals and humans. The success of deworming depends on highly effective and low-toxic anthelmintic agents, many of which, despite a wide range, do not meet modern requirements.